M. Ladouceur , G. Gennesseaux , V. Gruschen , Pregnancy Outcomes In Fontans With Anticoagulation Therapy (profit) Inverstigator
{"title":"Pregrancy in Fontan patients: Should we refine the current recommendations?","authors":"M. Ladouceur , G. Gennesseaux , V. Gruschen , Pregnancy Outcomes In Fontans With Anticoagulation Therapy (profit) Inverstigator","doi":"10.1016/j.acvdsp.2023.07.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Pregnancies in patients with a Fontan circulation are high-to very high-risk pregnancies. European and American recommendations consider patients with any Fontan complications should be counseled against becoming pregnant.</p></div><div><h3>Objective</h3><p>This study sought to evaluate maternal complications in patients with Fontan circulation according to the modified WHO (mWHO) classification.</p></div><div><h3>Methods</h3><p><span>We performed a retrospective observational cohort study across 13 international centers. Maternal and fetal outcomes were reviewed according to baseline risk assessed as per the mWHO classification. Women with oxygen saturations <</span> <span>85%, NYHA<span><span> functional class IV, depressed ventricular function, moderate to severe atrioventricular valve regurgitation, refractory arrhythmia, plastic </span>bronchitis, or protein-losing enteropathy (PLE) were considered at very high risk of complications (mWHO IV), those without any Fontan complication were classified at high risk (mWHO III). The risk of remaining patients who experienced other types of Fontan complications was classified as mWHO III–IV.</span></span></p></div><div><h3>Results/Expected results</h3><p>We analyzed 84 women (median age 27 years, interquartile range 23-30) with Fontan physiology undergoing 108 complete pregnancies, average gestation of 33<!--> <!-->±<!--> <!-->5 weeks. Fifty-two (48%) pregnancies were classified as mWHO III, 45 (42%) mWHO III–IV, and 11 (10%) mWHO IV (<span>Table 1</span>). None patients had a previous history of PLE or plastic bronchitis. There was no maternal death. Cardiovascular complications occurred in 13 (25%), 16 (35%) and 4 (36%) pregnancies classified mWHO III, III–IV, and IV respectively (<em>P</em> <!-->=<!--> <!-->0.74). Cardiovascular complication rates remained not significantly different when patients with any Fontan complications were compared to patients without (36% vs. 25%, <em>P</em> <!-->=<!--> <!-->0.23; <span>Table 1</span>). There were high rates of fetal (<em>n</em> <!-->=<!--> <!-->73, 68%) and obstetrical (<em>n</em> <!-->=<!--> <!-->75, 69% including 38 bleeding events) complications without significant difference between the 3 risk groups.</p></div><div><h3>Conclusion/Perspectives</h3><p>Maternal cardiovascular complications occurred in one-third of pregnancies whatever the mWHO classification. Even if there is no reported maternal death, women with Fontan circulation should be carefully counseled on pregnancy risks.</p></div>","PeriodicalId":8140,"journal":{"name":"Archives of Cardiovascular Diseases Supplements","volume":"15 4","pages":"Pages 274-275"},"PeriodicalIF":18.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1878648023002264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Pregnancies in patients with a Fontan circulation are high-to very high-risk pregnancies. European and American recommendations consider patients with any Fontan complications should be counseled against becoming pregnant.
Objective
This study sought to evaluate maternal complications in patients with Fontan circulation according to the modified WHO (mWHO) classification.
Methods
We performed a retrospective observational cohort study across 13 international centers. Maternal and fetal outcomes were reviewed according to baseline risk assessed as per the mWHO classification. Women with oxygen saturations <85%, NYHA functional class IV, depressed ventricular function, moderate to severe atrioventricular valve regurgitation, refractory arrhythmia, plastic bronchitis, or protein-losing enteropathy (PLE) were considered at very high risk of complications (mWHO IV), those without any Fontan complication were classified at high risk (mWHO III). The risk of remaining patients who experienced other types of Fontan complications was classified as mWHO III–IV.
Results/Expected results
We analyzed 84 women (median age 27 years, interquartile range 23-30) with Fontan physiology undergoing 108 complete pregnancies, average gestation of 33 ± 5 weeks. Fifty-two (48%) pregnancies were classified as mWHO III, 45 (42%) mWHO III–IV, and 11 (10%) mWHO IV (Table 1). None patients had a previous history of PLE or plastic bronchitis. There was no maternal death. Cardiovascular complications occurred in 13 (25%), 16 (35%) and 4 (36%) pregnancies classified mWHO III, III–IV, and IV respectively (P = 0.74). Cardiovascular complication rates remained not significantly different when patients with any Fontan complications were compared to patients without (36% vs. 25%, P = 0.23; Table 1). There were high rates of fetal (n = 73, 68%) and obstetrical (n = 75, 69% including 38 bleeding events) complications without significant difference between the 3 risk groups.
Conclusion/Perspectives
Maternal cardiovascular complications occurred in one-third of pregnancies whatever the mWHO classification. Even if there is no reported maternal death, women with Fontan circulation should be carefully counseled on pregnancy risks.
期刊介绍:
Archives of Cardiovascular Diseases Supplements is the official journal of the French Society of Cardiology. The journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles, editorials, and Images in cardiovascular medicine. The topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Additionally, Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.